Wednesday, February 10, 2010, 9:09pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Targacept, Inc. (TRGT)

At 5:00AM SGT: 20.51 USD   0.00 (0.00%)  
 MORE ON TRGT 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Targacept, Inc. (NGM:TRGT) Delayed quote dataEdit
Last Trade:20.51 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:20.51
Open:N/A
Bid:0.01 x 100
Ask:2,000.00 x 100
1y Target Est:28.50
Day's Range:N/A - N/A
52wk Range:2.00 - 24.50
Volume:0
Avg Vol (3m):243,014
Market Cap:568.13M
P/E (ttm):N/A
EPS (ttm):-0.74
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add TRGT to Portfolio   Download Data

 HEADLINES 
•Targacept Awarded a Grant from The Michael J. Fox Foundation to Conduct Biomarker Research for Parkinson's Disease
Business Wire (Mon, Feb 8)
•Targacept to Report Fourth Quarter and 2009 Financial Results on February 11, 2010
Business Wire (Thu, Feb 4)
•Targacept to Present at BIO CEO & Investor Conference
Business Wire (Tue, Feb 2)
•1-Star Stocks Poised to Plunge: Cytori Therapeutics?
at Motley Fool (Fri, Jan 29)
•TARGACEPT INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Tue, Jan 26)
•Targacept execs to speak at Bio event
at bizjournals.com (Thu, Jan 21)
•1-Star Stocks Poised to Plunge: Dollar Thrifty?
at Motley Fool (Tue, Jan 19)
•Targacept gets $200M payment from AstraZeneca
AP (Tue, Jan 12)
•Will the Bull Trend End & 3 Power Ratings Stocks
TradingMarkets.com (Tue, Jan 12)
•Targacept banks $200M payment
at bizjournals.com (Mon, Jan 11)
More Headlines for TRGT...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.87
EPS Est (in 2 years) (Dec-10) :0.80
Avg Rec (current)*:1.6
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Targacept, Inc., a biopharmaceutical company, engages in the design, discovery, and development of neuronal nicotinic receptor (NNR) Therapeutics for the treatment of diseases and disorders of the central nervous system.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices